National Academies of Sciences Engineering and Medicine: Examining Glucagon-Like Peptide-1 Receptor (Glp-1r)..., Kartoniert / Broschiert
National Academies of Sciences Engineering and Medicine, Health And Medicine Division, Board On Health Sciences Policy, Forum on Neuroscience and Nervous System Disorders
Examining Glucagon-Like Peptide-1 Receptor (Glp-1r) Agonists for Central Nervous System Disorders
Buch
- Proceedings of a Workshop
Erscheint bald
Lassen Sie sich über unseren eCourier benachrichtigen, sobald das Produkt bestellt werden kann.
Lassen Sie sich über unseren eCourier benachrichtigen, sobald das Produkt bestellt werden kann.
- Auswahl:
- Sheena M Posey Norris, Eva Childers, Robert Pool
- Verlag:
- National Academies Press, 11/2025
- Einband:
- Kartoniert / Broschiert
- Sprache:
- Englisch
- ISBN-13:
- 9780309735056
- Umfang:
- 118 Seiten
- Erscheinungstermin:
- 27.11.2025
- Hinweis
-
Achtung: Artikel ist nicht in deutscher Sprache!
Ähnliche Artikel
National Academies of Sciences Engineering and Medicine, Division On Earth And Life Studies, Division on Engineering and Physical Sciences, Nuclear And Radiation Studies Board
The Current Status and Future Direction of High-Magnetic-Field Science and Technology in the United States
Buch
Aktueller Preis: EUR 31,57
National Academies of Sciences Engineering and Medicine, Division on Engineering and Physical Sciences, Space Studies Board, Aeronautics and Space Engineering Board
NASA at a Crossroads
Buch
Aktueller Preis: EUR 63,15
National Academies of Sciences Engineering and Medicine, Policy And Global Affairs, Board On Higher Education And Workforce, Committee on the Development of a Plan to Promote Defense Research at Historically Black Colleges and Universities Tribal Colleges and Universities Hispanic-Serving Institutions and Other Minority-Serving Institutions
A Plan to Promote Defense Research at Minority-Serving Institutions
Buch
Aktueller Preis: EUR 27,78
Klappentext
Glucagon-like peptide-1 receptor (GLP-1R) agonists, originally developed for type 2 diabetes patients and popularized by their ability to rapidly reduce body weight in patients with obesity, have recently received a lot of national attention. Repurposing GLP-1R agonists to treat some central nervous disorders is promising, but comparatively understudied. At a September 2024 workshop, the National Academies Forum on Neuroscience and Nervous System Disorders reviewed the current knowledge and research gaps about the mechanisms of action of GLP-1R agonists in the brain, and the evidence of their clinical efficacy for eating disorders, neurodegenerative diseases, substance use disorders, and pain.
Mehr von National Academ...
-
National Academies of Sciences Engineering and MedicineEnding Unequal TreatmentBuchVorheriger Preis EUR 65,68, reduziert um 0%Aktueller Preis: EUR 62,52
-
National Academies of Sciences Engineering and MedicineCompounding Disasters in Gulf Coast Communities 2020-2021BuchAktueller Preis: EUR 42,94
-
National Academies of Sciences Engineering and MedicineThriving on Our Changing PlanetBuchVorheriger Preis EUR 55,57, reduziert um 0%Aktueller Preis: EUR 51,78
-
National Academies of Sciences Engineering and MedicineEquity in K-12 Stem EducationBuchAktueller Preis: EUR 56,84
